Statins After 70: Trial Finds More Heart Events, No Benefit When Stopped

An international clinical trial involving 1,880 adults aged 70 and older has tested whether patients taking cholesterol-lowering pills for primary prevention can safely stop the medication as they age.

Mondosanità reported that the study, titled STREAM, followed participants across 24 clinical centers in Switzerland, France, and the Netherlands to evaluate the consequences of discontinuing statins.

The trial enrolled patients with a mean age of 77.5 years, where 46.9% were women, all of whom had at least two chronic conditions and no history of cardiovascular disease. Researchers randomly assigned 938 participants to stop taking statins, while 942 continued their daily treatment. Medico e paziente said that the trial ran between November 2021 and April 2026.

At the two-year mark, patients who stopped the therapy lived an average of two weeks less without a major event compared to those who kept taking the pills.

While the trial met its statistical criteria for non-inferiority, tracking the actual number of clinical events revealed a divergence between the two groups. Among those who discontinued the medication, 12.7% experienced a major event or died, compared to 9.2% in the group that continued treatment.

The findings were published on November 7, 2026, in the New England Journal of Medicine by Nicolas Rodondi, Moa Lina Haller, Julia Bianca Bardoczi and their colleagues. Mondosanità reported that stopping the medication failed to produce measurable improvements in daily well-being, muscle pain, falls, or muscle mass loss.

Tracking the actual number of clinical events during the median follow-up of 103 weeks revealed a noticeable divergence between the two study arms. Mondosanita reported that 119 individuals out of the 938 who stopped taking statins experienced a major event or died, amounting to 12.7% of that group.

By comparison, 87 out of the 942 participants who continued their daily medication experienced such events, representing 9.2% of the group. This absolute difference of 3.5 percentage points meant that discontinuation was linked to 32 more events among those who stopped the pharmaceutical treatment.

Medico e paziente said that previous investigations had assessed the safety of stopping primary prevention statins in individuals aged 70 or older without finding differences in overall mortality. Some earlier research had even suggested that stopping these pills might improve a patient’s quality of life.

Despite those earlier findings, the STREAM study authors emphasized that a collaborative decision-making process between patients and healthcare providers is essential. Medico e paziente reported study author Rita F. explaining that discontinuing the medication remains generally safe for most individuals in this age bracket who lack a prior cardiovascular event.

The trial results were also presented at the American Heart Association Scientific Sessions 2026, according to Mondosanità. Commenting on what stopping preventative lipid-lowering treatments in later life means more widely, study author Rita F. pointed to the delicate balance required when managing multimorbidity in older adults.

Photo of author

Health Desk

Health Desk at Archyde.

Microsoft to Retire To Do Apps on June 30, 2027

Magnitude 2.2 Quake Northeast of Clearlake, Weak Shaking in Cobb